{
    "name": "degarelix",
    "comment": "Rx",
    "other_names": [
        "Firmagon"
    ],
    "classes": [
        "Antineoplastics",
        "Antiandrogens",
        "Antineoplastics",
        "GNRH Antagonists"
    ],
    "source": "https://reference.medscape.com/drug/firmagon-degarelix-999105",
    "pregnancy": {
        "common": [
            "Safety and efficacy not established in women"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Based on findings in animal studies and mechanism of action, drug can cause fetal harm and loss of pregnancy when administered to a pregnant woman; there are no human data on use of drug in pregnant women to inform drug-associated risk; in animal developmental and reproductive toxicity studies in rats and rabbits, oral administration of degarelix during organogenesis caused embryo-fetal lethality and abortion as well as increased post-implantation loss and decreased number of live fetuses in animals at doses less than clinical loading dose based on body surface area; advise pregnant patients and females of reproductive potential of potential risk to fetus",
                    "Based on findings in animals and mechanism of action, degarelix may impair fertility in males and females of reproductive potential"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Safety and efficacy not established in females; there are no data on presence of drug in human milk, effects on breastfed child, or on milk production; because many drugs are present in human milk and because of potential for serious adverse reactions in a breastfed child from therapy, a decision should be made whether to discontinue nursing or discontinue drug taking into account importance of drug to mother"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity",
                "Pregnancy or in women who may become pregnant"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Severe hepatic impairment",
                "Long-term androgen deprivation treatment prolongs QT interval, this is increased risk with congenital long QT syndrome, electrolyte abnormalities, CHF, coadministration with antiarrhythmic agents from Class IA [eg, quinidine, procainamide)]or Class III [eg, amiodarone, sotalol]); consider whether benefits of androgen deprivation therapy outweigh potential risks",
                "Bone mineral density may decrease due to androgen deprivation therapy",
                "Risk for diabetes may increase due to androgen deprivation, which may cause obesity and insulin resistance",
                "Hypersensitivity reactions (eg, anaphylaxis, urticaria, angioedema) reported; if a serious hypersensitivity reaction occurs, discontinue drug immediately if the injection has not been completed, and manage as clinically indicated; do not rechallenged"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Hot flashes",
            "percent": "26"
        },
        {
            "name": "Injection site erythema",
            "percent": "17"
        },
        {
            "name": "Injection site pain",
            "percent": "28"
        },
        {
            "name": "Weight gain",
            "percent": "11"
        },
        {
            "name": "Elev liver enzymes",
            "percent": "10"
        },
        {
            "name": "Arthralgia",
            "percent": null
        },
        {
            "name": "Back pain",
            "percent": null
        },
        {
            "name": "Fatigue",
            "percent": null
        },
        {
            "name": "HTN",
            "percent": null
        },
        {
            "name": "Injection site induration",
            "percent": null
        },
        {
            "name": "swelling",
            "percent": null
        },
        {
            "name": "Decreased bone density",
            "percent": null
        }
    ]
}